D-1273-2019 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1273-2019 was initiated by Zydus Pharmaceuticals USA Inc on Apr 25, 2019 and is designated Class II. Reason for recall: Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg The recall status is terminated (terminated Jun 29, 2021). Affected quantity: 3900.

Recall details

Product Type
Drugs
Report Date
May 15, 2019
Initiation Date
Apr 25, 2019
Termination Date
Jun 29, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3900

Product description

Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-093-05

Reason for recall

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

Distribution pattern

Nationwide

Code information

Z804517, exp Nov 30, 2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1273-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1273-2019. Report a data issue: hello@regdatalab.com.